EXPRESSION OF LATS2 AND STK17B DISTINGUISHES EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) GENE MUTATIONS IN EXONS 19 AND 21 FROM THOSE IN 18 AND 20 IN LUNG ADENOCARCINOMAS

被引：0
|
作者：
Lam, David C. [1 ]
Girard, Luc [2 ]
Beer, David G. [3 ]
Kris, Mark G. [4 ]
Ladanyi, Marc [5 ]
Gerald, William L. [4 ]
Sihoe, Alan D. [1 ]
Cheng, Lik-Cheung [1 ]
Wong, Maria P. [1 ]
Chung, Lap Ping [1 ]
Ip, Mary [1 ]
Lam, Wah Kit [1 ]
Gazdar, Adi F. [2 ]
Wistuba, Ignacio I. [6 ]
Minna, John D. [2 ]
机构：
[1] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China
[2] Univ Texas Southwestern Med Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX USA
[3] Univ Michigan, Ann Arbor, MI 48109 USA
[4] Mem Sloan Kettering Canc Ctr, Med Thorac Oncol Serv, New York, NY USA
[5] Mem Sloan Kettering Canc Ctr, New York, NY USA
[6] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S734 / S734
页数：1
相关论文
共 11 条
  • [1] Use of cigarette-smoking history to estimate the likelihood of mutations in epidermal growth factor receptor gene exons 19 and 21 in lung adenocarcinomas
    Pham, DK
    Kris, MG
    Riely, GJ
    Sarkaria, IS
    McDonough, T
    Chuai, SK
    Venkatraman, ES
    Miller, VA
    Ladanyi, M
    Pao, W
    Wilson, RK
    Singh, B
    Rusch, VW
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (11) : 1700 - 1704
  • [2] Lack of epidermal growth factor receptor gene mutations in exons 19 and 21 in primary lymphoepithelioma-like carcinoma of the lung
    Liu, Qianwen
    Ma, Guowei
    Yang, Haoxian
    Wen, Jing
    Li, Mei
    Yang, Hong
    Luo, Kongjia
    Hu, Yi
    Fu, Jianhua
    THORACIC CANCER, 2014, 5 (01) : 63 - 67
  • [3] Epidermal growth factor receptor (EGFR) gene mutations in exons 18 and 20 in patients with advanced colorectal cancer are more frequent than commonly believed
    Metzger, Brigitte
    Pauly, Marc
    Faber, Carlo
    Kayser, Jacques
    Roman, Francois
    Bosseler, Manon
    Dicato, Mario
    ANNALS OF ONCOLOGY, 2006, 17 : 249 - 249
  • [4] Epidermal growth factor receptor (EGFR) double-activating somatic mutations in exons 19 and 21 in Japanese non-small cell lung cancer patients
    Masago, Katsuhiro
    Fujita, Shiro
    Kim, Young Hak
    Ichikawa, Masataka
    Hatachi, Yukimasa
    Fukuhara, Akiko
    Nagai, Hiroki
    Irisa, Kaoru
    Mio, Tadashi
    Mishima, Michiaki
    CANCER GENETICS AND CYTOGENETICS, 2009, 195 (02) : 179 - 182
  • [5] Gene Expression Signature Associated With Combined Characteristics Of Female Non-smokers In Lung Adenocarcinomas Bearing Activating Epidermal Growth Factor Receptor (EGFR) Gene Mutations In Chinese
    Lam, D.
    Girard, L.
    Sihoe, A. D.
    Cheng, L.
    Lui, M. M.
    Wong, M. P.
    Chung, L.
    Ip, M. S.
    Lam, W.
    Minna, J. D.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [6] Immunohistochemistry detection of epidermal growth factor receptor (EGFR) exons 19 and 21 mutations in non-small cell lung cancer (NSCLC) using novel mutation specific antibodies
    Kato, Y.
    Peled, N.
    Yoshida, K.
    Wynes, A. W.
    Pardo, A.
    Mascaux, C. J.
    Tsubol, M.
    Ohira, T.
    Ikeda, N.
    Hirsch, F. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] Detection of epidermal growth factor receptor (EGFR) exon 19 E746-A750 deletion and EGFR exon 21 point mutations in lung adenocarcinoma by immunohistochemistry: a comparative study to EGFR exons 19 and 21 mutations analysis using PCR followed by high-resolution melting and pyrosequencing
    Chabot-Richards, Devon
    Buehler, Karen
    Vasef, Mohammad A.
    JOURNAL OF HISTOTECHNOLOGY, 2015, 38 (02) : 56 - 62
  • [8] High epidermal growth factor receptor immunohistochemical expression in urothelial carcinoma of the bladder is not associated with EGFR mutations in exons 19 and 21: a study using formalin-fixed, paraffin-embedded archival tissues
    Chaux, Alcides
    Cohen, Julie S.
    Schultz, Luciana
    Albadine, Roula
    Jadallah, Sana
    Murphy, Kathleen M.
    Sharma, Rajni
    Schoenberg, Mark P.
    Netto, George J.
    HUMAN PATHOLOGY, 2012, 43 (10) : 1590 - 1595
  • [9] Updated molecular analyses of exons 19 and 21 of the epidermal growth factor receptor (EGFR) gene and codons 12 and 13 of the KRAS gene in non-small cell lung cancer (NSCLC) patients treated with erlotinib in National Cancer Institute of Cancer
    Shepherd, F. A.
    Ding, K.
    Sakurada, A.
    Santos, G. Da Cunha
    Zhu, C.
    Seymour, L.
    Whitehead, M.
    Kamel-Reid, S.
    Squire, J.
    Tsao, M. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [10] A single-arm, phase II study of amivantamab (AMI), lazertinib (L) and pemetrexed (P) for first-line treatment of recurrent/metastatic non-small cell lung cancers (NSCLCS) with epidermal growth factor receptor mutations in Exons 19 or 21 (EGFR 19/21): AMIGO 1 (LACOG0821)
    William Junior, W. Nassib
    de Lima Araujo, L. H.
    Da Silva, F. A. F.
    Gelatti, A. C.
    Silva, E. H. C.
    Melo Cruz, F. J. Silva
    De Castro, G., Jr.
    Abdalla, K. C.
    Zereu, M.
    De Marchi, P. R.
    Aleixo, S. Bandeira
    Sousa Oliveira, S. Cunha
    Motta, T. Cardoso
    de Jesus, R.
    Rebelatto, T. F.
    ANNALS OF ONCOLOGY, 2023, 34
12